Whalesbook
Indian Earnings Roundup: Q4 FY26 Results for Key Companies
Over 190 Indian companies released their fourth-quarter fiscal year 2026 results on May 22, 2026, drawing particular attention to Sun Pharmaceutical Industries, Hindalco Industries, and Eicher Motors. Investors are closely examining revenue, profit margins, and management commentary for insights into future performance and potential dividends. The overall market sentiment is influenced by broader economic trends and global factors affecting supply chains and market risk appetite.
Sun Pharma: Growth Expected Amidst Margin Pressure
Analysts forecast Sun Pharmaceutical Industries to achieve a 12% year-over-year revenue increase, reaching approximately ₹14,492 crore for the March quarter. However, this growth is anticipated alongside a reduction in EBITDA margins, projected to fall to 27.2% from 29% a year earlier. Despite this, EBITDA is expected to rise 6% to ₹3,946 crore, with net profit forecast to increase by 28% to ₹2,762 crore. The company's global specialty business, boosted by new launches and existing products, is projected to hit $400 million in sales. The Indian market is expected to grow by 13% year-over-year, supported by a new semaglutide product. US sales are estimated between $469-$500 million, showing modest year-over-year growth but remaining flat sequentially due to typical insurance re-verification processes early in the year. Sun Pharma currently trades at a P/E ratio of about 41.46, slightly above the industry average. Its market capitalization is around $46.60 billion USD as of May 2026.
Hindalco and Eicher Motors: Strong Revenue Projections
Hindalco Industries is expected to report strong results, with revenue estimates around ₹74,073 crore and a profit of ₹4,579 crore. EBITDA is anticipated at ₹9,154 crore, with margins near 12%. The company's market capitalization is approximately ₹2.47 lakh crore. Hindalco's P/E ratio stands around 14.71, slightly above the non-ferrous metals industry average. Eicher Motors is projected to announce revenue of ₹5,965 crore, EBITDA of ₹1,489 crore, and a net profit of ₹1,455 crore. Eicher Motors's market capitalization is approximately ₹1.90 lakh crore. The company's P/E ratio is around 40.84, higher than peers like Bajaj Auto. Its historical P/E has averaged around 39.6x for the past five fiscal years.
Sector Performance and Valuations
The overall Indian earnings season shows a split, with mid-cap companies reporting 29% growth compared to large-caps' 14% increase in Q4 FY26. The IT, BFSI, auto, metals, utilities, real estate, and oil & gas sectors are performing well, while pharmaceuticals and utilities are lagging.
Hindalco's P/E ratio of 14.71 is considered fairly valued within the non-ferrous metals industry. The company has delivered strong long-term performance, with a five-year gain of 180.88% compared to the Sensex's gain of 49.80%. However, its subsidiary Novelis reported a net loss of $84 million for Q4 FY26 due to fire disruptions at its Oswego plant, despite net sales increasing 4% to $4.8 billion, supported by higher aluminum prices. The market reacted positively to Hindalco shares, suggesting a focus on the anticipated restart of operations.
Sun Pharma trades at a premium valuation with a P/E of 37.25, about 7.9% higher than the Pharmaceuticals & Biotechnology sector average. While its short-term returns have outpaced the Sensex, its ten-year return of 139.03% lags the Sensex's 197.93%.
Eicher Motors, with a P/E of around 40.84, also trades at a premium to its peers. ICICI Securities forecasts Eicher Motors to post ₹1,254 crore net profit for Q4 FY26, an 11.5% year-over-year increase, with net sales projected up 13.7% to ₹5,805.1 crore. However, a sequential decline in profit and sales is anticipated, as the automotive sector shifts focus to mass-market vehicles.
Potential Challenges
For Sun Pharma, narrowing EBITDA margins despite revenue growth could indicate cost pressures or a shift to lower-margin products. The flat to slightly lower sequential US sales due to insurance processes highlight operational complexities in a dynamic pharmaceutical sector.
Hindalco faces challenges from operational disruptions, such as the fire at its Oswego plant that impacted Novelis's profitability. While operations are expected to resume, such incidents pose a risk to consistent earnings. Global aluminum prices and trade policies also affect profitability.
Eicher Motors's premium valuation could be a concern if future growth targets are missed or sequential sales decline. The automotive sector's evolving focus on electric vehicles also requires monitoring for long-term competitive positioning, even as Eicher concentrates on its core motorcycle business.
Future Outlook
Analysts predict a strong Q4 FY26 for NTPC Green Energy, with revenue estimated between ₹1,800–2,100 crore and profit after tax (PAT) at ₹280–350 crore. The company's capacity additions and improved generation are expected to drive performance. For the broader market, the focus is shifting to FY27, with Nifty EPS growth projected at 8.5%, a reduction from the previous 14% estimate due to the West Asia conflict. The current earnings season will be critical in determining if the FY27 recovery outlook remains viable amidst geopolitical uncertainties impacting inflation, employment, and GDP growth.